Clinical Trial

Fluorescence Image Guided Foregut Surgery

Study acronym: FOREGUT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
A high number of resected lymph nodes is an independent prognostic factor for improved survival after esophagectomy or gastrectomy for cancer. The quality of the lymphadenectomy is operator-dependent, as is the evaluation of the vascularization of the digestive structures that are anastomosed to restore digestive continuity after esophago-gastric resection. The aim of the study is to evaluate the impact of Indocyanine Green (ICG) and near infra-red (NIR) fluorescence imaging guidance in terms of number of lymph nodes resected and quality of gastrointestinal tract anastomoses in esophagogastric cancer surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-01-28; most recent amendment 2025-04-29.
Status change: Not Yet Recruiting → Recruiting 2022-03-28
Trial Details
NCT Number NCT04734821
Lead Sponsor IHU Strasbourg
Conditions Esophageal Cancer, Gastric Cancer
Enrollment 60 participants
Start Date 2021-04-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-01